Secor Capital Advisors’s AnaptysBio ANAB Stock Holding History

Secor Capital Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,577	Closed	-$292K	–	403
2018 Q4	$292K	Buy	+4,577	New	+$340K	0.04%	376

Other funds holding ANAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Secor Capital Advisors's ANAB Position: Q1 2019 in Review

Secor Capital Advisors sold out of AnaptysBio (ANAB) in Q1 2019, closing a stake of 4,577 shares — an estimated $292K sold.

Secor Capital Advisors first reported a position in ANAB in Q4 2018 and held it in 1 quarter. The position peaked at $292K in Q4 2018. 129 funds tracked by Wall St. Rank hold ANAB as of Q1 2019.

Secor Capital Advisors reported no remaining AnaptysBio position as of Q1 2019 after selling out during the quarter.
Secor Capital Advisors sold 4,577 AnaptysBio shares in Q1 2019, an estimated $292K.
Secor Capital Advisors first reported a position in AnaptysBio in Q4 2018 and held it in 1 quarter.
Secor Capital Advisors's AnaptysBio position peaked at $292K in Q4 2018.
129 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2019.

Based on Secor Capital Advisors's 13F filing for Q1 2019, filed 15 May 2019.